References
- KissinICan a bibliometric indicator predict the success of a drug?Scientometrics201186785795
- KissinIBradleyELJrTop Journals Selectivity Index: is it acceptable for drugs beyond the field of analgesia?Scientometrics201188589597
- KissinIBradleyELJrTop Journal Selectivity Index and ‘me-too’ drugsScientometrics201291131142
- KissinIAn early indicator of drug success: Top Journal Selectivity IndexDrug Des Devel Ther201379398
- CorrellDJVlassakovKVKissinINo evidence of real progress in treatment of acute pain, 1993–2012: scientometric analysisJ Pain Res2014719921024748816
- KissinIScientometric assessment of drugs for chronic pain, 1979–2013; rapid growth of publications, paucity of successful drugsJ Pain Res2014750551425187736
- VlassakovKVKissinIScientometrics of anesthetic drugs and their techniques of administration, 1984–2013Drug Des Devel Ther2014824632473
- KissinIThe study on the development of new analgesics over the past 50 years: a lack of real breakthrough drugsAnesth Analg201011078078920185657
- HillRGAnalgesic drugs in developmentMcMahonSBKolzenburgMWall and Melzack’s Textbook of Pain5th edPhiladelphia, PA, USAElsevier Churchill Livingstone2006
- DrayAPharmacological modulation of painBasbaumAIBushnellMCScience of Pain AmsterdamThe NetherlandsElsevier2009
- HeinzmannSMcMahonSBNew molecules for the treatment of painCurr Opin Support Palliat Care2011511111521455071
- HayesAGArendt-NielsenLTateSMultiple mechanisms have been tested in pain – how can we improve the chances of success?Curr Opin Pharmacol201414111724565006
- BurgessGWilliamsDThe discovery and development of analgesics: new mechanisms, new modalitiesJ Clin Invest20101203753375921041957
- KissinIGelmanSChronic postsurgical pain: still a neglected topic?J Pain Res2012547348923152698
- JarvisMFThe neural-glial purinergic receptor ensemble in chronic pain statesTrends Neurosci201033485719914722
- BrileyMNew hope in the treatment of painful symptoms in depressionCurr Opin Investig Drugs200344245
- KanekoYSzallasiATransient receptor potential (TRP) channels: a clinical perspectiveBr J Pharmacol20141712474250724102319
- KissinISzallasiATherapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trialsCurr Top Med Chem2011112159217021671878
- McNamara Pharmacotherapy of the epilepsiesBrunionLChabnerBAKnollmannBCGoodman and Gilman’s Pharmacological Basis of Therapeutics12th edNew York, NY, USAMcGraw-Hill2011
- KukkarABaliASinghNJaggiASImplications and mechanism of action of gabapentin in neuropathic painArch Pharm Res20133623725123435945
- BellRFDahlJBMooreRAKalsoEPerioperative ketamine for acute postoperative painCochrane Database Syst Rev20061CD00460316437490
- LuongoLMaioneSDiMarzoVEndocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactionsEur J Neurosci20143940140824494680
- Cernuda-MorollónERamónCLarrosaDAlvarezRRiescoNPascualJLong-term experience with onabotulinumtoxinA in the treatment of chronic migraine: what happens after one year?Cephalalgia11272014 Epub ahead of print
- EdvinssonLCGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatmentBr J Clin Pharmacol332015 Epub ahead of print
- NelsonALDhimoleaEReichertJMDevelopment trends for human monoclonal antibody therapeuticsNat Rev Drug Discov2010976777420811384
- WangHRomanoGFrustaciMEFulranumab for treatment of diabetic peripheral neuropathic pain: a randomized controlled trialNeurology20148362863725008392
- SpieringsELFidelholtzJWolframGSmithMDBrownMTWestCRA phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or kneePain20131541603161223707270
- IskedjianMBerezaBGordonAPiwkoCEinarsonTRMeta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related painCurr Med Res Opin200723172417257464